| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/28/2011 | EP2367428A1 Organic compounds |
| 09/28/2011 | EP2367426A1 Phenazopyridine compounds |
| 09/28/2011 | EP2367425A1 Combinations and modes of administration of therapeutic agents and combination therapy |
| 09/28/2011 | EP2367422A1 Enema formulations |
| 09/28/2011 | EP2367421A1 Oral formulations |
| 09/28/2011 | EP2244703B1 Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies |
| 09/28/2011 | EP2148876B1 Pyrazolone derivatives as pde4 inhibitors |
| 09/28/2011 | EP2133335B1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/28/2011 | EP2120915B1 Polyelectrolyte precipitation and purification of antibodies |
| 09/28/2011 | EP2103305B1 Therapeutic agent for diabetic neuropathy |
| 09/28/2011 | EP2041137B1 Pyrrolopyrimidines for pharmaceutical compositions |
| 09/28/2011 | EP2041131B1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 09/28/2011 | EP1981510B1 A pharmaceutical composition comprising oenothein c useful for the treatment of peptic ulcer diseases |
| 09/28/2011 | EP1962838B1 Farnesoid x receptor agonists |
| 09/28/2011 | EP1945201B1 Calcium receptor activator |
| 09/28/2011 | EP1926722B1 Substituted benzimidazoles as kinase inhibitors |
| 09/28/2011 | EP1912972B1 Substituted imidazole compounds as ksp inhibitors |
| 09/28/2011 | EP1885704B1 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
| 09/28/2011 | EP1881827B1 Fused thiazole derivatives as kinase inhibitors |
| 09/28/2011 | EP1864131B1 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/28/2011 | EP1861363B1 Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors |
| 09/28/2011 | EP1845990B1 Treatment of metastasized tumors |
| 09/28/2011 | EP1828107B1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use |
| 09/28/2011 | EP1806132B1 Stat3 phosphorylation inhibitor and notch1 expression inhibitor |
| 09/28/2011 | EP1781600B1 Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors |
| 09/28/2011 | EP1741716B1 Process for producing pentacyclic taxane |
| 09/28/2011 | EP1697344B1 Hiv protease inhibiting compounds |
| 09/28/2011 | EP1673058B1 Composition and method for promoting hair growth |
| 09/28/2011 | EP1643999B1 Pyridoxamine for use in the treatment of diabetic neprhopathy in type ii diabetes |
| 09/28/2011 | EP1617835B1 Compounds for the treatment of metabolic disorders |
| 09/28/2011 | EP1605890B1 Kit for pharmaceutical use |
| 09/28/2011 | EP1508335B1 Compositions comprising a cocoa fraction for use in the treatment of periodontitis caused by bacteria belonging to genus porphyromonas, prevotella, fusobacterium or actinobacillus |
| 09/28/2011 | EP1463531B1 Methods for inhibiting ocular processes |
| 09/28/2011 | EP1424330B1 Activator for peroxisome proliferator-responsive receptor delta |
| 09/28/2011 | EP1420809B1 Use of cyclopenta[g]quinazoline derivatives for treating cancer |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | EP1414386B1 Canine cardiac diet |
| 09/28/2011 | EP1355669B1 Augmented cognitive training |
| 09/28/2011 | EP1353684B8 Use of inhibitors of dipeptidypeptidase iv (ec 3.3.14.5) and aminopeptidase n (ec 3.4.11.2) for the treatment of neurodegeneration induced by ischaemia |
| 09/28/2011 | EP1322307B1 Methods for treating cell proliferative disorders and viral infections |
| 09/28/2011 | EP1263965B1 Avirulent, immunogenic flavivirus chimeras |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | EP1004305B1 Stabilized compositions containing benzimidazole-type compounds |
| 09/28/2011 | CN1994380B Externally applied medicine for treating arthritis, hot pack and preparation method thereof |
| 09/28/2011 | CN1980661B Cationic bacteriochlorophyll derivatives and uses thereof |
| 09/28/2011 | CN1964714B Use of suberoylanilide hydroxamic acid and gemcitabine in preparing medicine for treating cancer |
| 09/28/2011 | CN1961877B Pharmaceutical composition for treating withdrawal syndrome |
| 09/28/2011 | CN1915981B 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 09/28/2011 | CN1903182B Miniaturization sarpogrelate hydrochloride oral drug-giving preparation |
| 09/28/2011 | CN1897951B Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 09/28/2011 | CN1795174B Novel substituted 3-sulfur indoles |
| 09/28/2011 | CN1646139B Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 09/28/2011 | CN1630712B Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 09/28/2011 | CN1344159B Combinations for treatment of diseases involving angiogenesis |
| 09/28/2011 | CN102203250A Syngr4 for target genes of cancer therapy and diagnosis |
| 09/28/2011 | CN102203112A Certain chemical entities, compositions, and methods |
| 09/28/2011 | CN102203110A Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/28/2011 | CN102203103A Derivatives of 1-amino-2-cyclobutylethylboronic acid |
| 09/28/2011 | CN102203101A Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents |
| 09/28/2011 | CN102203100A Cephalosporin having catechol group |
| 09/28/2011 | CN102203099A Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same |
| 09/28/2011 | CN102203098A Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors |
| 09/28/2011 | CN102203095A Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/28/2011 | CN102203094A Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments |
| 09/28/2011 | CN102203093A Aminotriazolopyridines and their use as kinase inhibitors |
| 09/28/2011 | CN102203092A Alfa-carboline inhibitors of npm-alk, ret, and bcr-abl |
| 09/28/2011 | CN102203089A N-sulfonamido polycyclic pyrazolyl compounds |
| 09/28/2011 | CN102203088A Poly-heteroaryl derivatives for the treatment of cancer |
| 09/28/2011 | CN102203085A Processes for the preparation of crystalline forms of sunitinib malate |
| 09/28/2011 | CN102203084A Nilotinib hci crystalline forms |
| 09/28/2011 | CN102203083A Compounds and compositions as kinase inhibitors |
| 09/28/2011 | CN102203081A Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 09/28/2011 | CN102203079A Picolinamide derivatives as kinase inhibitors |
| 09/28/2011 | CN102203078A P38 MAPK kinase inhibitor |
| 09/28/2011 | CN102203077A ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain |
| 09/28/2011 | CN102203075A Bicyclic kinase inhibitors |
| 09/28/2011 | CN102203074A Aryl GPR119 agonists and uses thereof |
| 09/28/2011 | CN102203068A Cyclohexane derivative and pharmaceutical use thereof |
| 09/28/2011 | CN102203067A Hedgehog pathway modulators |
| 09/28/2011 | CN102203065A Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists |
| 09/28/2011 | CN102203064A Novel benzamides, production thereof, and use thereof as medicaments |
| 09/28/2011 | CN102203063A Carbazole compounds and therapeutic uses of the compounds |
| 09/28/2011 | CN102203061A Selective seprase inhibitors |
| 09/28/2011 | CN102203060A 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 09/28/2011 | CN102203059A Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 09/28/2011 | CN102203058A Sulfur-linked compounds for treating opthalmic diseases and disorders |
| 09/28/2011 | CN102203056A Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof |
| 09/28/2011 | CN102203055A Nitric oxide releasing amino acid ester compound, composition and method of use |
| 09/28/2011 | CN102202737A Disubstituted phthalazine hedgehog pathway antagonists |
| 09/28/2011 | CN102202693A Use of a truncated elf-5a1 polynucleotide to induce apoptosis in cancer cells |
| 09/28/2011 | CN102202691A Lactose and cellulose-based tableting aid |
| 09/28/2011 | CN102202676A Dna-directed customization of analgesic compounds as a therapeutic modality |
| 09/28/2011 | CN102202675A Standardized extract and fraction from hancornia speciosa leaves and pharmaceutical composition thereof |
| 09/28/2011 | CN102202673A Pharmaceutical compositions containing diacerein |
| 09/28/2011 | CN102202672A Methods for treating or preventing pain using spicamycin derivatives |
| 09/28/2011 | CN102202671A Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin |
| 09/28/2011 | CN102202670A Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
| 09/28/2011 | CN102202669A Modulators of aldehyde dehydrogenase and methods of use thereof |
| 09/28/2011 | CN102202668A Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor |
| 09/28/2011 | CN102202667A Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |